Cargando...
Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants
BACKGROUND: Persistent patent ductus arteriosus (PDA) is associated with mortality and morbidity in preterm infants. Prostaglandin synthetase inhibitors such as indomethacin promote PDA closure but also have potential side effects. The effect of the prophylactic use of indomethacin, where infants wh...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2010
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045285/ https://ncbi.nlm.nih.gov/pubmed/20614421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000174.pub2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|